Tools to study β3-adrenoceptors

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 374, Issue 5-6, 2007, Pages 385-398

  Vrydag, Wim ^a   Michel, Martin C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

3 adrenoceptor; BRL 37,344; CGP 12,177; Knock out mice; Radioligand; SR 59,230

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 [2 [(2 HYDROXY 3 PHENOXYPROPYL)AMINO]ETHOXY]PHENOXYACETIC ACID; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ADRENALIN; ALPRENOLOL; ATENOLOL; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BISOPROLOL; BUPRANOLOL; CARVEDILOL; CLENBUTEROL; FK 175; FR 149175; FR 165701; FR 175; GS 332; ISOPRENALINE; KUL 7211; L 748337; L 755507; L 796568; METOPROLOL; N [4 [2 [[3 [3(ACETAMIDOMETHYL)PHENOXY] 2 HYDROXYPROPYL]AMINO]ETHYL]PHENYLBENZENESULFONAMIDE]; NORADRENALIN; PINDOLOL; PROPRANOLOL; RECEPTOR SUBTYPE; SOTALOL; SULFONAMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZINTEROL;

AGONIST; ANALYTIC METHOD; BLADDER; BLOOD VESSEL; DRUG ACTIVITY; DRUG EFFICACY; DRUG SELECTIVITY; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; KNOCKOUT MOUSE; LIGAND BINDING; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; RECEPTOR BINDING; RECEPTOR BLOCKING; REGULATORY MECHANISM; REVIEW; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; DRUG ANTAGONISM; DRUG POTENTIATION; GENE EXPRESSION PROFILING; GENETICS; MOLECULAR GENETICS; MOUSE; MOUSE MUTANT; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; GENE EXPRESSION PROFILING; HUMANS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; RECEPTORS, ADRENERGIC, BETA-3; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 33846839074     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-006-0127-5     Document Type: Review

References (125)

1. Alemzadeh R, Tushaus KM (2004) Modulation of adipoinsular axis in prediabetic Zucker diabetic fatty rats by diazoxide. Endocrinol 145:5476-5484
2. Anonymous (2003) SR 58611A. Drugs R D 4:380-382
3. 3-adrenoceptor agonists: potential, pitfalls and progress. Eur J Pharmacol 440:99-107
4. 3 and atypical β-adrenoceptors. Med Res Rev 13:663-729
5. 3-adrenoceptor agonist induces pancreatic islet blood flow and insulin secretion in rats. Eur J Pharmacol 298:287-292
6. Baker JG (2005) The selectivity of β-adrenoceptor antagonists at the human β1, β2 and β3 adrenoceptors. Br J Pharmacol 144:317-322
7. 3- adrenoceptor activation on basal tone of internal anal sphincter. Am J Physiol 285:G547-G555
8. 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. Br J Pharmacol 117:907-913
9. 3-adrenoceptor mRNA in human tissues. Eur J Pharmacol 289:223-228
10. 3-adrenoceptor. Br J Pharmacol 112:911-919
11. 2- adrenoceptors mediating relaxation in rat isolated aorta. Br J Pharmacol 138:99-106
12. 3- or atypical β-adrenoceptors in rat aorta. Br J Pharmacol 142:781-787
13. 3-adrenoceptors in smooth muscle cells of rat small mesenteric arteries. Br J Pharmacol 146:679-691
14. Brown L, Deighton NM, Bals S, Söhlmann W, Zerkowski H-R, Michel MC, Brodde O-E (1992) Spare receptors for β-adrenoceptor-mediated positive inotropic effects of catecholamines in the human heart. J Cardiovasc Pharmacol 19:222-232
15. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR Jr, Trendelenburg U (1994) IV. International Union of Pharmacology Nomenclature of Adrenoceptors. Pharmacol Rev 46:121-136
16. 3- adrenergic receptor antagonists. J Pharmacol Exp Ther 290:649-655
17. 3-adrenoceptor in human adipose tissue, atrium and skeletal muscle. Int J Obesity 23:1057-1065
18. 3-adrenergic receptor. J Pharmacol Exp Ther 271:1253-1258
19. 3 receptors and rat atrial receptors mediating tachycardia. Br J Pharmacol 126:1018-1024
20. 1-adrenergic receptors are resistant to agonist-mediated regulation in human SK-N-MC neurotumor cells. Cell Signal 8:355-364
21. 3 adrenoceptor in nebivolol-induced vasorelaxation in the rat aorta. J Cardiovasc Pharmacol 42:232-235
22. 3-adrenoceptors in human brown and white adipose tissue. Br J Pharmacol 118:929-934
23. 2 adrenoceptor knockout mice. Mol Pharmacol 60:577-583
24. 3-adrenergic receptor. Science 245:1118-1121
25. 1- and atypical β-adrenergic receptors cause redundant increases in cyclic AMP in human neuroblastoma cells. Mol Pharmacol 42:753-759
26. 3-adrenoceptor mRNA in rat tissues. Br J Pharmacol 117:210-216
27. 3-adrenoceptor which are differentially expressed in mouse tissues. Br J Pharmacol 127:1525-1531
28. 3- adrenergic receptor. J Biol Chem 266:20329-20336
29. Feve B, Baude B, Krief S, Strosberg AD, Pairault J, Emorine LJ (1992) Inhibition by dexamethasone of β3-adrenergic receptor responsiveness in 3T3-F442A adipocytes. Evidence for a transcriptional mechanism. J Biol Chem 267:15909-15915
30. 3- adrenergic receptor in 3T3-F4424 adipocytes. J Biol Chem 270:10952-10959
31. 3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys. J Clin Invest 101:2387-2393
32. Fletcher DS, Candelore MR, Grujic D, Lowell BB, Luell S, Susulic VS, Macintyr DE (1998) Beta-3 adrenergic receptor agonists cause an increase in gastrointestinal transit time in wild-type mice, but not in mice lacking the beta-3 adrenergic receptor. J Pharmacol Exp Ther 287:720-724
33. 3-receptor agonist (BRL 37,344) and a partial agonist (CGP 12,177) in neonatal rat liver plasma membranes. Biochem Pharmacol 44:2333-2338
34. Frazier EP, Schneider T, Michel MC (2006) Effects of gender, age and hypertension on β-adrenergic receptor function in rat urinary bladder. Naunyn-Schmiedeberg's Arch Pharmacol 373:300-309
35. 3-adrenoceptor in human and rat detrusor muscle. J Urol 161:680-685
36. 3-adrenergic receptor. Mol Pharmacol 40:895-899
37. 3-adrenergic receptor genes contain an intron within the proteincoding block. Mol Pharmacol 42:964-970
38. 1A receptors. Mol Pharmacol 41:695-698
39. Guimaraes S, Moura D (2001) Vascular adrenoceptors: an update. Pharmacol Rev 53:319-356
40. 3-adrenergic receptor agonist, on energy expenditure in Zucker fatty rats. Am J Physiol 287:R336-R341
41. Hoffmann C, Leitz MR, Oberdorf-Maass S, Lohse MJ, Klotz K-N (2004) Comparative pharmacology of human β-adrenergic receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedeberg's Arch Pharmacol 369:151-159
42. Hollenga C, Brouwer F, Zaagsma J (1991) Differences in functional cyclic AMP compartments mediating lipolysis by isoprenaline and BRL 37344 in four adipocyte types. Eur J Pharmacol 200:325-330
43. Horinouchi T, Koike K (2001) Agonist activity of SR59230A at atypical β-adrenoceptors in guinea pig gastric fundus and duodenum. Eur J Pharmacol 416:165-168
44. 125I] iodocyanopindolol. Eur J Pharmacol 118:1-12
45. 3-adrenoceptor knock-out mice. Br J Pharmacol 132:433-442
46. 3b-adrenoceptors expressed in Chinese hamster ovary cells display identical pharmacology but utilize distinct signalling pathways. Br J Pharmacol 135:1903-1914
47. 3-adrenoceptor revealed by SR59230A [3-(2-ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1- ylamino]-2S-2-propanol oxalate]. J Pharmacol Exp Ther 312:1064-1074
48. 3- adrenoceptor. Naunyn-Schmiedeberg's Arch Pharmacol 373:158-168
49. Igawa Y, Yamazaki Y, Takeda H, Akahane M, Ajisawa Y, Yoneyama T, Nishizawa O (1998) Possible β3-adrenoceptor-mediated relaxation of the human detrusor. Acta Physiol Scand 164:117-118
50. 3-adrenoceptor in the human detrusor muscle. Br J Pharmacol 126:819-825
51. Igawa Y, Yamazaki Y, Takeda H, Kaidoh K, Akahane M, Ajisawa Y, Yoneyama T, Nishizawa O, Andersson K-E (2001) Relaxant effects of isoproterenol and selective β3-adrenoceptor agonists on normal, low compliant and hyperreflexic human bladders. J Urol 165:240-244
52. Jasper JR, Michel MC, Insel PA (1988) Molecular mechanism of β-adrenergic blockers with intrinsic sympathomimetic activity (ISA). FASEB J 2:2891-2894
53. 1-adrenoceptor in human atrium and recombinant receptors. Naunyn-Schmiedeberg's Arch Pharmacol 368:496-503
54. 1-adrenoceptor. Naunyn-Schmiedeberg's Arch Pharmacol 370:223-226
55. 1- adrenoceptors and interaction with β-blockers. Naunyn-Schmiedeberg's Arch Pharmacol 369:525-532
56. 3-adrenoceptor agonists in detrusor hyperreflexia in conscious cerebral infarcted rats. J Urol 168:1247-1252
57. Kaumann AJ (1996) (-)-CGP 12177-induced increase of human atrial contraction through a putative third β-adrenoceptor. Br J Pharmacol 117:93-98
58. 3-adrenoceptor in the rat. Br J Pharmacol 118:2085-2098
59. 3- adrenoceptor knockout mice. Mol Pharmacol 53:670-675
60. 4-adrenoceptor pharmacology. Naunyn-Schmiedeberg's Arch Pharmacol 363:87-93
61. 3-adrenergic receptor gene expression in brown adipocytes in culture. Mol Cell Endocrinol 109:189-195
62. 3-adrenergic receptor overexpressed in the hearts of transgenic mice. Circulation 104:2485-2491
63. Konkar AA, Zhai Y, Granneman JG (2000) β1-Adrenergic receptors mediate β3-adrenergic-independent effects of CGP 12177 in brown adipose tissue. Mol Pharmacol 57:252-258
64. 3-agonists, CGP 12177A and BRL 37344, on coronary flow and contractility in isolated guinea pig heart. J Cardiovasc Pharmacol 41:706-713
65. Kubota Y, Nakahara T, Yunoki M, Mitani A, Maruko T, Sakamoto K, Ishii K (2002) Inhibitory mechanism of BRL37344 on muscarinic receptor-mediated contractions of the rat urinary bladder smooth muscle. Naunyn-Schmiedeberg's Arch Pharmacol 366:198-203
66. Kuratani K, Kodama H, Yamaguchi I (1994) Enhancement of gastric mucosal blood flow by beta-3 adrenergic agonists prevents indomethacin-induced antral ulcer in the rat. J Pharmacol Exp Ther 270:559-565
67. Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG (1967) Differentiation of receptor systems activated by sympathetic amines. Nature 214:597-598
68. 3-adrenoceptor ligands in rat pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 371:535-539
69. Lefrere I, de Coppet P, Camelin J-C, Le Lay S, Mercier N, Elshourbagy N, Bril A, Berrebi-Bertrand I, Feve B, Krief S (2002) Neuropeptide AF and FF modulation of adipocyte metabolism. Primary insights from functional genomics and effects on β-adrenergic responsiveness. J Biol Chem 277:39169-39178
70. Lelias JM, Kaghad M, Rodriguez M, Chalon P, Bonnin J, Dupre I, Delpech B, Bensaid M, LeFur G, Ferrara P, Caput D (1993) Molecular cloning of a human β3-adrenergic receptor cDNA. FEBS Lett 324:127-130
71. 3-adrenergic receptors increases brain tryptophan. J Pharmacol Exp Ther 305:653-659
72. 3-adrenergic receptors: differential agonist activation of recombinant receptors in Chinese hamster ovary cells. Mol Pharmacol 42:634-637
73. Longhurst PA, Levendusky M (1999) Pharmacological characterization of β-adrenoceptors mediating relaxation of the rat urinary bladder in vitro. Br J Pharmacol 127:1744-1750
74. 1- adrenoceptor-induced relaxation in spontaneously hypertensive rats. Br J Pharmacol 143:599-605
75. 3-selective antagonists, aryloxypropanolaminotetralins. Br J Pharmacol 117:435-442
76. Matsubara S, Okada H, Shirakawa T, Gotoh A, Kuno T, Kamidono S (2002) Estrogen levels influence beta-3-adrenoceptor-mediated relaxation of the female rat detrusor muscle. Urology 59:621-625
77. 2- and β-adrenoceptors in the urinary bladder, urethra and prostate. Br J Pharmacol 147:S88-S119
78. 2- adrenoceptors in the human heart by chronic β-adrenoceptor antagonist treatment. Br J Pharmacol 94:685-692
79. 3-adrenoceptors. Br J Pharmacol 120:165-176
80. Moniotte S, Vaerman J-L, Kockx MM, Larrouy D, Langin D, Noirhomme P, Balligand J-L (2001) Real-time RT-PCR for the detection of beta-adrenoceptor messenger RNAs in small human endomyocardial biopsies. J Mol Cell Cardiol 33:2121-2133
81. 3-Adrenoceptor switch in 3T3-L1 preadipocytes and adipocytes: modulation by testosterone, 17β-estradiol, and progesterone. Am J Physiol 289:E145-E150
82. 3-adrenoceptors in rat, rabbit and human urinary bladder and external urethral sphincter. J Smooth Muscle Res 36:21-32
83. Murakami M, Tomiyama Y, Hayakawa K, Akahane M, Ajisawa Y, Park Y-C, Ohnishi N, Sugiyama T, Kurita T (2000) Effects of β-adrenergic stimulation on acutely obstructed ureter in dogs. J Pharmacol Exp Ther 292:67-75
84. Muzzin P, Revelli J-P, Kuhne F, Gocayne JD, McCombie WR, Venter JC, Giacobino J-P, Fraser CM (1991) An adipose tissue-specific β-adrenergic receptor. Molecular cloning and down-regulation in obesity. J Biol Chem 266:24053-24058
85. 3H]SB 206606. Mol Pharmacol 46:357-363
86. Nahmias C, Blin N, Elalouf J-M, Mattei MG, Strosberg AD, Emorine LJ (1991) Molecular characterization of the mouse β3-adrenergic receptor: relationship with the atypical receptor of adipocytes. EMBO J 10:3721-3727
87. Niclauß N, Michel-Reher MB, Alewijnse AE, Michel MC (2006) Comparison of three radioligands for the labelling of human β-adrenoceptor subtypes. Naunyn-Schmiedeberg's Arch Pharmacol 374:79-85
88. 3- adrenoceptor agonists SR 58611A and SR 58878A but not by BRL 37344 or ICI 215,001. J Neurochem 65:1580-1587
89. 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes. Mol Pharmacol 49:7-14
90. Nomiya M, Yamaguchi O (2003) A quantitative analysis of mRNA expression of α1 and β-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J Urol 170:649-653
91. 3-adrenoceptor knockout mice. Br J Pharmacol 130:747-758
92. Oshita M, Hiraoka Y, Watanabe Y (1997) Characterization of β-adrenoceptors in urinary bladder: comparison between rat and rabbit. Br J Pharmacol 122:1720-1724
93. Park YC, Tomiyama Y, Hayakawa K, Akahane M, Ajisawa Y, Miyatake R, Kiwamoto H, Sugiyama T, Kurita T (2000) Existence of a β3-adrenoceptor and its functional role in the human ureter. J Urol 164:1364-1370
94. 3 adrenergic receptor agonist. Bioorgan Med Chem Lett 8:1107-1112
95. 3-adrenergic receptors. Fundam Clin Pharmacol 9:211-218
96. 3-adrenoceptors in human atrial myocardium. Br J Pharmacol 138:521-529
97. 3-adrenoceptor knock-out mice: evidence for a new β-adrenergic receptor in brown adipose tissue. Br J Pharmacol 124:1684-1688
98. 125I]-cyanopindolol binding sites in rat soleus muscle. Br J Pharmacol 109:344-352
99. 3-adrenoceptors in human colon. Br J Pharmacol 120:1527-1535
100. 3-adrenergic effect on lipolysis in human subcutaneous adipose tissue. J Clin Endocrinol Metab 77:352-355
101. 3-Adrenoceptors in the cardiovascular system: putative roles in human pathologies. Pharmacol Ther 111 (3):652-673
102. 3-adrenoceptor agonist in lower esophageal sphincter smooth muscle: in vitro studies. J Pharmacol Exp Ther 304:48-55
103. 3-adrenoceptor associated with differential G protein coupling. J Pharmacol Exp Ther 315:1354-1361
104. 3-adrenoceptors in rat detrusor muscle. J Urol 159:2197-2201
105. Staehelin M, Simons P, Jaeggi K, Wigger N (1983) CGP-12177. A hydrophilic β-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells. J Biol Chem 258:3496-3502
106. Sugasawa T, Matsuzaki-Fujita M, Guillaume J-L, Camoin L, Morooka S, Strosberg AD (1997) Characterization of a novel iodocyanopindolol and SM-11044 binding protein, which may mediate relaxation of depolarized rat colon tonus. J Biol Chem 272:21244-21252
107. 3-adrenergic receptor gene. J Biol Chem 270:29483-29492
108. 3-adrenoceptor agonist, CL316,243, and various smooth muscle relaxants. J Pharmacol Exp Ther 293:939-945
109. Takeda H, Yamazaki Y, Akahane M, Akahane S, Miyata H, Igawa Y, Nishizawa O (2002a) Characterization of β-adrenoceptor subtype in bladder smooth muscle of cynomolgus monkey. Jpn J Pharmacol 88:108-113
110. 2-induced bladder hyperreactivity and on the cardiovascular system in conscious rats. Neurourol Urodyn 21:558-565
111. Takeda H, Matsuzawa A, Igawa Y, Yamazaki Y, Kaidoh K, Akahane S, Kojima M, Miyata H, Akahane M, Nishizawa O (2003) Functional characterization of β-adrenoceptor subtypes in the canine and rat lower urinary tract. J Urol 170:654-658
112. Tate KM, Briend-Sutren M-M, Emorine LJ, Delavier-Klutchko C, Marullo S, Strosberg AD (1991) Expression of three human β-adrenergic-receptor subtypes in transfected chinese hamster ovary cells. Eur J Biochem 196:357-361
113. 3-adrenoceptor agonist. Br J Pharmacol 112:55-58
114. 3-adrenergic receptor expression via multiple cAMP response elements. Proc Natl Acad Sci USA 89:4490-4494
115. Tomiyama Y, Murakami M, Hayakawa K, Akiyama K, Yamazaki Y, Kojima M, Shibata N, Akahane M (2003) Pharmacological profile of KUL-7211, a selective β-adrenoceptor agonist, in isolated ureteral smooth muscle. J Pharmacol Sci 92:411-419
116. Uchida H, Shishido K, Nomiya M, Yamaguchi O (2005) Involvement of cyclic AMP-dependent and -independent mechanisms in the relaxation of rat detrusor muscle via β-adrenoceptors. Eur J Pharmacol 518:195-202
117. 3-adrenoceptor agonist in human omental adipocytes. Diabetes 48:117-120
118. 3-adrenergic receptor agonist, on energy expenditure in obese men. Clin Pharmacol Ther 71:272-279
119. Wilson S, Chambers JK, Park JE, Ladurner A, Cronk DW, Chapman CG, Kallender H, Browne MJ, Murphy GJ, Young PW (1996) Agonist potency at the cloned human beta-3 adrenoceptor depends on receptor expression level and nature of assay. J Pharmacol Exp Ther 279:214-221
120. Woods M, Carson N, Norton NW, Sheldon JH, Argentieri TM (2001) Efficacy of the β3-adrenergic receptor agonist CL-316243 on experimental bladder hyperreflexia and detrusor instability in the rat. J Urol 166:1142-1147
121. 3-adrenoceptors in mediating relaxation of porcine detrusor muscle. Br J Pharmacol 135:129-134
122. Yamanishi T, Chapple CR, Yasuda K, Yoshida K, Chess-Williams R (2002b) Identification of β-adrenoceptor subtypes in lower urinary tract of the female pig. J Urol 168:2706-2710
123. Yamanishi T, Chapple CR, Yasuda K, Yoshida K, Chess-Williams R (2003) Role of β-adrenoceptor subtypes in mediating relaxation of the pig bladder trigonal muscle in vitro. Neurourol Urodyn 22:338-342
124. 3- adrenergic stimulation in failing rat heart. J Pharmacol Exp Ther 315:1203-1211
125. 2 double knockout mice. Mol Pharmacol 58:887-894